Cargando…

Protocol: Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease

BACKGROUND: 40% of Parkinson's Disease (PD) sufferers experience insomnia, impacting health and quality of life for patients and family members, especially carers. There is little evidence that current treatments are effective. OBJECTIVES: To determine the effectiveness of melatonin in reducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikles, J., O'Sullivan, J.D., Mitchell, G.K., Smith, S.S., McGree, J.M., Senior, H., Dissanyaka, N., Ritchie, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626998/ https://www.ncbi.nlm.nih.gov/pubmed/31338478 http://dx.doi.org/10.1016/j.conctc.2019.100397

Ejemplares similares

A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial
por: Alemayehu, Chalachew, et al.
Publicado: (2017)

Personalised treatments for acute whiplash injuries: A pilot study of nested N-of-1 trials in a multiple baseline single-case experimental design
por: Nikles, J., et al.
Publicado: (2019)

Comparing pregabalin and gabapentin for persistent neuropathic pain: A protocol for a pilot N-of-1 trial series
por: Bashford, Guy, et al.
Publicado: (2021)

Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies
por: Blackston, J. Walker, et al.
Publicado: (2019)

Pediatric sleep disturbances and treatment with melatonin
por: Esposito, Susanna, et al.
Publicado: (2019)

Melatonin and Sleep Disturbances in Children With Atopic Dermatitis
por: Dwiyana, Reiva Farah, et al.
Publicado: (2022)

Parkinson's Disease and Sleep/Wake Disturbances
por: Swick, Todd J.
Publicado: (2012)

Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial
por: Punja, Salima, et al.
Publicado: (2016)

Parkinson’s Disease: A Narrative Review on Potential Molecular Mechanisms of Sleep Disturbances, REM Behavior Disorder, and Melatonin
por: Samizadeh, Mohammad-Ali, et al.
Publicado: (2023)

Establishment of an International Collaborative Network for N-of-1 Trials and Single-Case Designs
por: Nikles, Jane, et al.
Publicado: (2021)

Adaptive monitoring of coral health at Scott Reef where data exhibit nonlinear and disturbed trends over time
por: Abeysiri Wickrama Liyanaarachchige, Pubudu Thilan, et al.
Publicado: (2022)

Sleep Disturbances Associated with Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2011)

Management of Sleep Disturbances in Parkinson’s Disease
por: Schütz, Lukas, et al.
Publicado: (2022)

Editorial: Sleep disturbances in Parkinson's disease
por: Salsone, Maria, et al.
Publicado: (2023)

Sleep disturbances in Parkinson’s disease patients and management options
por: Claassen, Daniel O, et al.
Publicado: (2011)

Sleep disturbances and depression severity in patients with Parkinson's disease
por: Kay, Daniel B., et al.
Publicado: (2018)

Parental Experiences of Melatonin Administration to Manage Sleep Disturbances in Autistic Children and Adolescent in the UK
por: Horsnell, Jade, et al.
Publicado: (2023)

Sleep disturbances in Parkinson’s disease are associated with central parkinsonian pain
por: Vila-Chã, N, et al.
Publicado: (2019)

Sleep disturbances in Taiwanese patients with Parkinson's disease
por: Lin, Yi‐Ying, et al.
Publicado: (2017)

Fatigue correlates with sleep disturbances in Parkinson disease
por: Cao, Xiang-Yang, et al.
Publicado: (2021)

Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
por: Xu, Zheyu, et al.
Publicado: (2022)

Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
por: Chang, Yung-Sen, et al.
Publicado: (2016)

A Comparative Study on the Use of Alprazolam and Melatonin for Sleep Disturbances in Hemodialysis Patients
por: Asghar, Muhammad Sohaib, et al.
Publicado: (2020)

Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022)

The Impact of Spatial Scales and Spatial Smoothing on the Outcome of Bayesian Spatial Model
por: Kang, Su Yun, et al.
Publicado: (2013)

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease
por: Liu, Chun-Feng, et al.
Publicado: (2018)

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease
por: Minakawa, Eiko N.
Publicado: (2022)

Sleep Disturbances in Parkinson's Disease: Is It Related to COVID-19?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2022)

Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
por: Hu, Xinyu, et al.
Publicado: (2023)

Delirium and sleep disturbances in COVID–19: a possible role for melatonin in hospitalized patients?
por: Zambrelli, Elena, et al.
Publicado: (2020)

Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats
por: Hao, Shu‐Mei, et al.
Publicado: (2021)

Effects of melatonin on sleep disturbances in multiple sclerosis: A randomized, controlled pilot study
por: Hsu, Wan-Yu, et al.
Publicado: (2021)

RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework
por: Bellgard, Matthew I., et al.
Publicado: (2019)

Sleep Disturbances and Sleep Disordered Breathing Impair Cognitive Performance in Parkinson’s Disease
por: Hermann, Wiebke, et al.
Publicado: (2020)

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis
por: Puelles, J., et al.
Publicado: (2021)

Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial
por: Grima, Natalie A., et al.
Publicado: (2018)

Oral melatonin for non‐respiratory sleep disturbance in children with neurodisabilities: systematic review and meta‐analyses
por: Parker, Adwoa, et al.
Publicado: (2019)

Correlation of Sleep Disturbance and Cognitive Impairment in Patients with Parkinson’s Disease
por: Kim, Eun Ja, et al.
Publicado: (2014)

Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2019)

Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson’s Disease
por: Lin, Chia-Yen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vi39akakfspj7266e8cu2dknhg